Search results
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 3 days agoPharmaceutical segment revenues beat the Zacks Consensus Estimate of $13.53 billion and our model...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 3 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 3 days agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 2 days agoBoth companies reported quarterly earning Thursday, providing insights into how the drug...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 2 days agoThe adjustment comes in the wake of Merck's first-quarter results, which not only featured a robust...
...Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in...
Morningstar· 5 days agoThe VERSATILE-002 trial is evaluating Versamune® HPV (formerly PDS0101) in combination with the immune checkpoint...
Merck beats earnings forecasts as cancer drug sales boom
Crain's New York Business· 3 days agoThe guidance comes as Merck’s first-quarter earnings topped $15.8 billion, a 9% increase from the...
Merck jumps on profit beat as Bristol Myers Squibb slips to a loss
Proactive Investors· 3 days agoMerck & Co Inc (NYSE:MRK, ETR:6MK), the pharmaceutical firm, saw its shares tick 3.5% higher after...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoSales in our Animal Health business increased 4% across both companion animal and livestock products. Turning to the performance of our key brands. In...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 2 days agoCore earnings per share are also expected to increase in the low double-digit to low teens...